203 related articles for article (PubMed ID: 29571225)
21. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
22. Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin.
Meng Q; Yu X; Chen Q; Wu X; Kong X; Wang S; Cai D; Cheng P; Li Y; Bian H
J Ethnopharmacol; 2020 Jan; 246():112207. PubMed ID: 31476440
[TBL] [Abstract][Full Text] [Related]
23. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
24. Huayu Qutan Recipe promotes lipophagy and cholesterol efflux through the mTORC1/TFEB/ABCA1-SCARB1 signal axis.
Li Y; Pan J; Yu JJJ; Wu X; Yang G; Pan X; Sui G; Wang M; Cheng M; Zhu S; Tai H; Xiao H; Xu L; Wu J; Yang Y; Tang J; Gong L; Jia L; Min D
J Cell Mol Med; 2024 Apr; 28(8):e18257. PubMed ID: 38526033
[TBL] [Abstract][Full Text] [Related]
25. Effect of miR-663 on atherosclerosis by regulating the proliferation of vascular smooth muscle cells in lipid plaques.
Deng Z; Li L
Vascular; 2023 Dec; 31(6):1240-1252. PubMed ID: 35599617
[TBL] [Abstract][Full Text] [Related]
26. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
27. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
28. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effect of (-)-Epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis.
Li W; Yu J; Xiao X; Li W; Zang L; Han T; Zhang D; Niu X
Eur J Pharmacol; 2021 Jan; 891():173761. PubMed ID: 33249078
[TBL] [Abstract][Full Text] [Related]
31. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress
Yu J; Li W; Xiao X; Huang Q; Yu J; Yang Y; Han T; Zhang D; Niu X
Food Funct; 2021 Sep; 12(18):8715-8727. PubMed ID: 34365492
[TBL] [Abstract][Full Text] [Related]
33. Oxidized Low-Density Lipoprotein-Induced Cyclophilin A Secretion Requires ROCK-Dependent Diphosphorylation of Myosin Light Chain.
Su Z; Lin R; Chen Y; Shu X; Zhang H; Liang S; Nie R; Wang J; Xie S
J Vasc Res; 2016; 53(3-4):206-215. PubMed ID: 27825172
[TBL] [Abstract][Full Text] [Related]
34. Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy.
Bao Y; Zhu L; Wang Y; Liu J; Liu Z; Li Z; Zhou A; Wu H
Phytomedicine; 2024 Jun; 128():155341. PubMed ID: 38518636
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
[TBL] [Abstract][Full Text] [Related]
36. Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells.
Ma KL; Ruan XZ; Powis SH; Moorhead JF; Varghese Z
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2721-8. PubMed ID: 17322416
[TBL] [Abstract][Full Text] [Related]
37. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
[TBL] [Abstract][Full Text] [Related]
38. Sinigrin attenuates the progression of atherosclerosis in ApoE
Jang YJ; Park B; Lee HW; Park HJ; Koo HJ; Kim BO; Sohn EH; Um SH; Pyo S
Chem Biol Interact; 2017 Jun; 272():28-36. PubMed ID: 28483571
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid decreases vascular smooth muscle cell proliferation via protein phosphatase 2A-mediated p70 S6 kinase inhibition.
Lee H; Hwang YJ; Park JH; Cho DH
Biochem Biophys Res Commun; 2022 May; 606():94-99. PubMed ID: 35339758
[TBL] [Abstract][Full Text] [Related]
40. Cav-1 promotes atherosclerosis by activating JNK-associated signaling.
Wang DX; Pan YQ; Liu B; Dai L
Biochem Biophys Res Commun; 2018 Sep; 503(2):513-520. PubMed ID: 29746866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
